Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07216677 · ClinicalTrials.gov registry record
A Real-World Study of Interventional Clinical Outcomes in Patients With Open Angle Glaucoma and Other Chronic Eye Diseases
A clinical trial of Glaucoma and Diabetic Retinopathy (DR), sponsored by Interstat.
- Active
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT07216677: Active study of Glaucoma and Diabetic Retinopathy (DR), sponsored by Interstat.
NCT07216677 is a study of Glaucoma and Diabetic Retinopathy (DR) that is active but no longer recruiting, run by Interstat. The registered enrollment target is 300 participants, below the 907-participant average among 92 other Glaucoma trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07216677, a study of Glaucoma and Diabetic Retinopathy (DR), is active but no longer recruiting, sponsored by Interstat.
- ACTIVE NOT RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a real world investigation of patient who have undergone treatments for chronic eye conditions such as glaucoma and AMD.
Primary Outcome
Longitudinal change in interventional chronic disease outcomes
Conditions Studied
Interventions
- OTHER Chronic Disease Intervention CDI
Study Locations (1)
New York
- Interstat - White Plains
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-10-10 |
| Est. Completion | 2027-10-25 |
What the registry record for NCT07216677 still lists
NCT07216677 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 907-participant average among 92 other Glaucoma trials with a reported enrollment target (67% lower).
The record links to 3 conditions, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which Chronic Disease Intervention CDI is the first listed.
NCT07216677 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07216677 about?
NCT07216677 is a clinical study titled "A Real-World Study of Interventional Clinical Outcomes in Patients With Open Angle Glaucoma and Other Chronic Eye Diseases". This is a real world investigation of patient who have undergone treatments for chronic eye conditions such as glaucoma and AMD.
What is the current status of trial NCT07216677?
This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2024-10-10. Estimated completion is 2027-10-25.
What conditions does trial NCT07216677 study?
This clinical trial studies the following conditions: Glaucoma, Diabetic Retinopathy (DR), AMD.
What interventions are being tested in trial NCT07216677?
The interventions under investigation include: Chronic Disease Intervention CDI (OTHER).
Who is sponsoring clinical trial NCT07216677?
This trial is sponsored by Interstat, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07216677 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07216677's enrollment target sits among peer trials
300 17th of 92 higher than 75 of 92 other Glaucoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Functional and Structural Imaging for Glaucoma
RECRUITING
-
Topical Insulin for Glaucoma
RECRUITING · Phase 1
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
RECRUITING · Phase 2
-
Eye Pressure Lowering Surgery
RECRUITING
-
Tolerability of an Anesthesia-free Tonometer Tip
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI